Does metabolic syndrome or its components associate with prostate cancer when diagnosed on biopsy?

PURPOSE To investigate the association between metabolic syndrome and prostate cancer risk in Turkish men. METHODS We examined data from 220 patients with prostate cancer and 234 men in a control group with benign biopsy results, who had a serum prostate-specific antigen (PSA) level ⩾ 4 ng/ml, or an abnormal digital rectal examination finding and who… (More)